1. Home
  2. SLGL

as of 11-28-2025 10:21am EST

$41.96
+$1.27
+3.11%
Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq

Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.

Chart Type:
Time Range:
Founded: 1997 Country:
Israel
Israel
Employees: N/A City: N/A
Market Cap: 69.1M IPO Year: 2018
Target Price: $50.00 AVG Volume (30 days): 18.6K
Analyst Decision: Strong Buy Number of Analysts: 1
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -3.23 EPS Growth: N/A
52 Week Low/High: $4.02 - $52.26 Next Earning Date: 11-20-2025
Revenue: $18,970,000 Revenue Growth: 62.04%
Revenue Growth (this year): -31.93% Revenue Growth (next year): -31.42%

AI-Powered SLGL Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 2 days ago

AI Recommendation

hold
Model Accuracy: 74.83%
74.83%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Stock Insider Trading Activity of Sol-Gel Technologies Ltd. (SLGL)

SLGL Nov 26, 2025

Avg Cost/Share

$40.00

Shares

943

Total Value

$37,720.00

Owned After

364,100

SEC Form 4

SLGL Nov 24, 2025

Avg Cost/Share

$35.50

Shares

6

Total Value

$213.00

Owned After

364,100

SEC Form 4

SLGL Nov 20, 2025

Avg Cost/Share

$35.83

Shares

5,784

Total Value

$207,243.61

Owned After

364,100

SEC Form 4

Share on Social Networks: